{"id":941370,"title":"Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-10","captureTimestamp":"2026-03-10T17:21:22.210000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years/summary-july-14-2022.html","snippet":"Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age Download in PDF format (498 KB, 6 pages) Organization: Public Health Agency of Canada Cat.: HP5-139/2-2022E-PDF ISBN:…","rawSnapshotUrl":"/api/snapshots/raw/941370","browseUrl":"https://replay.healtharchive.ca/job-7/20260310172122/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years/summary-july-14-2022.html#ha_snapshot=941370","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}